IL6 and cancer: There are increasing indications of a link between inflammation and the development of cancer where invasion-promoting factors (matrix metalloproteinases (MMPs) 2 and 9) and nuclear factor kappa B (NFκB)-dependent proinflammatory cytokine interleukin 6 (IL-6) support the malignant phenotype [11].